Taris Biomedical

Pharma

J&J's intravesical bladder cancer therapy Inlexzo lands FDA nod

The product is approved to treat patients with bladder cancer who face removal of the organ after not responding to the standard first-line treatment.

Zoey Becker Sep 10, 2025 10:50am